Insufficient Mitigation of Bone Loss by Zoledronic Acid after Treatment with Denosumab

Author: Jung-Wee PARK ¹
Author Information

1. Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
Publication Type:Letter to the Editor
From:Journal of Bone Metabolism 2021;28(4):339-341
CountryRepublic of Korea
Language:English